The Biosimilar And Biologics Market has experienced remarkable growth in recent years, driven by increasing prevalence of chronic diseases requiring targeted biological therapies, patent expirations of blockbuster reference biologics, and growing global pressure to reduce healthcare costs while expanding patient access. Biologics, complex molecules derived from living cells, have transformed...